Program
- 09:00 Opening – Giuseppe Gigli (Responsabile Scientifico – Cnr Nanotec)
- 09:15 OR1 Patients, receptors, viruses and plasmids for transduction – Ilaria Palamà (Cnr Nanotec)
- 09:30 OR2 LabOnChips (LoCs) for Critical Quality Attributes (CQA) monitoring – Francesco Ferrara (ST)
- 10:00 OR4 Validation and software control Serena Chiriacò (Cnr Nanotec)
- 10:15 OR5 Discovery of novel Critical Quality Attributes for engineered T-cell expansion – Graziano Pesole (Cnr IBIOM)
- 10:30 OR6 Systems for the non viral transduction †of T cells from patients – Giulio Caracciolo (Università La Sapienza)
- 10:45 OR7 Dissemination, exploitation and communication – Gabriella Zammillo (Cnr Nanotec)
Progetto PON ARS01_00906: finanziato dal FESR nell’ambito del PON “Ricerca e Innovazione” 2014 – 2020 – Azione II – OS 1.b)
Fonte: http://www.nanotec.cnr.it/en/titan-tumor-immunotherapy-by-nanotechnology-kick-off-e-meeting